Similar articles

• A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome.

  Van Outryve M, Mayeur S, Meeus MA, Rosillon D, Hendrickx B, Ceuppens M. Van Outryve M, et al. J Clin Pharm Ther. 1995 Oct;20(5):277-82. doi: 10.1111/j.1365-2710.1995.tb00663.x. J Clin Pharm Ther. 1995. PMID: 8576295 Clinical Trial.
• [Controlled clinical study of the action of mebeverine hydrochloride in the treatment of irritable colon].

  Secco GB, Di Somma C, Arnulfo G, Ricci C. Secco GB, et al. Minerva Med. 1983 Mar 31;74(13):699-702. Minerva Med. 1983. PMID: 6339996 Clinical Trial. Italian.
• Irritable colon syndrome treated with an antispasmodic drug.

  [No authors listed] [No authors listed] Practitioner. 1976 Aug;217(1298):276-80. Practitioner. 1976. PMID: 787960 Clinical Trial.
• [Drug treatment of irritable bowel syndrome: an unmet need].

  Mearin F. Mearin F. Gastroenterol Hepatol. 2007 Mar;30(3):130-7. doi: 10.1157/13100075. Gastroenterol Hepatol. 2007. PMID: 17374325 Review. Spanish. No abstract available.
• [The pain problem as a historic aspect. Pain at the biliary pathology. Mebeverine hydrochloride as a part of complex therapy].

  Paltsev AI, Voloshina NB, Eremina AA, Shishaeva LP, Kurganova IV, Iuz'ko IuIu, Savchenko NG, Borisov VI, Migus'kina EI. Paltsev AI, et al. Eksp Klin Gastroenterol. 2006;(2):83-94. Eksp Klin Gastroenterol. 2006. PMID: 16866271 Review. Russian. No abstract available.